Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016 (2016), Article ID 7231805, 3 pages
http://dx.doi.org/10.1155/2016/7231805
Case Report

First Report of Clostridium lavalense Isolated in Human Blood Cultures

1Service de Microbiologie Médicale et Maladies Infectieuses, Centre Hospitalier Universitaire Dr. Georges-L.-Dumont, Moncton, NB, Canada E1C 2Z3
2Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, Canada H9X 3R5
3Centre de Recherche en Infectiologie de l’Université Laval, Ville de Québec, QC, Canada G1V 4G2

Received 24 December 2015; Revised 27 April 2016; Accepted 19 May 2016

Academic Editor: José A. Oteo

Copyright © 2016 Richard Garceau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M.-C. Domingo, A. Huletsky, M. Boissinot et al., “Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces,” International Journal of Systematic and Evolutionary Microbiology, vol. 59, no. 3, pp. 498–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Bekal, C. Gaudreau, R. A. Laurence, E. Simoneau, and L. Raynal, “Streptococcus pseudoporcinussp. Nov., a novel species isolated from the genitourinary tract of women,” Journal of Clinical Microbiology, vol. 44, no. 7, pp. 2584–2586, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. Clinical and Laboratory Standards Institute, Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, M11-A8, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 8th edition, 2012.
  4. D. L. Stevens, A. E. Bryant, A. Berger, and C. von Eichel-Streiber, “Clostridium,” in Manual of Clinical Microbiology, J. Versalovic, Ed., pp. 834–857, ASM Press, Washington, DC, USA, 2011. View at Google Scholar
  5. K. Takahashi, A. Nishida, T. Fujimoto et al., “Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn's disease,” Digestion, vol. 93, no. 1, pp. 59–65, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Cohen-Poradosu and D. L. Kasper, “Anaerobic infections: general concepts,” in Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, J. E. Bennett, R. Dolin, and M. J. Blaser, Eds., pp. 2736–2743, Elsevier Saunders, Philadelphia, Pa, USA, 2015. View at Google Scholar
  7. A. B. Onderdonk and W. S. Garrett, “Gas gangrene and other Clostridium-associated diseases,” in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, J. E. Bennett, R. Dolin, and M. J. Blaser, Eds., pp. 2768–2772, Elsevier Saunders, Philadelphia, Pa, USA, 2015. View at Google Scholar
  8. A. Marchand-Austin, P. Rawte, B. Toye, F. B. Jamieson, D. J. Farrell, and S. N. Patel, “Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011,” Anaerobe, vol. 28, pp. 120–125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Leal, D. B. Gregson, T. Ross, D. L. Church, and K. B. Laupland, “Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000–2006,” Journal of Infection, vol. 57, no. 3, pp. 198–203, 2008. View at Publisher · View at Google Scholar · View at Scopus